FDA Archives

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

// Biotech and Pharma Therapeutics RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds March 4, 2024 / RSV / Pfizer / GSK / Arexvy After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s...

March 7, 2024

Metabolic News Weekly

Metabolic News Weekly: March 5, 2024

Akero’s New MASH Drug Data: Longer Treatment Leads to More Liver Benefit March 4, 2024 / MASH / Drug Development / Liver Disease Akero Therapeutics’ preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance...

March 5, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

// Biotech and Pharma Therapeutics Boehringer Ingelheim’s Liver Drug Data Position It for MASH Clash With Eli Lilly February 26, 2024 / Boehringer Ingelheim / Liver / New Drug / MASH / Eli Lilly Preliminary Phase 2 results show 83%...

February 29, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

// Biotech and Pharma Therapeutics Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance February 20, 2024 / Antibiotic Resistance / New Drug “It just got so frustrating over the years because we couldn’t find the source,...

February 22, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 16, 2024

// Biotech and Pharma Therapeutics Sage Touts Strong Launch for Postpartum Depression Drug Zurzuvae February 15, 2024 / Depression / Postpartum / Women’s Health / Sage Therapeutics Despite launching with just days left in 2023, Sage Therapeutics’ postpartum depression therapy...

February 16, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

// Biotech and Pharma Therapeutics BridgeBio sells partial rights to dwarfism drug for $100M February 7, 2024 / BridgeBio / Kyowa Kirin / BioMarin Achondroplasia is the most common form of dwarfism and is caused by alterations to a gene...

February 9, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 2, 2024

// Biotech and Pharma Therapeutics Endocrinology company Valendo Health launches with $4M and two provider partners January 31, 2024 / Endocrinology / Diabetes / Telehealth Valendo Health, a diabetes-focused, value-based endocrinology company, announced its launch with $4 million in seed...

February 2, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

// Biotech and Pharma Therapeutics Lilly gene therapy finding puts focus on hearing loss treatment pipeline January 24, 2024 / Eli Lilly / Gene Therapy / Drug Target / Hearing loss An 11-year-old boy who was born deaf can hear...

January 26, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

// Biotech and Pharma Therapeutics Kyverna sets plans for IPO in test of biotech enthusiasm January 17, 2024 / Kyverna / IPO / Startup More than two years after the bottom fell out for biotech stocks, the market for IPOs...

January 19, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

// Biotech and Pharma Therapeutics CRISPR pioneer Doudna allies with Danaher for gene editing center targeting rare disease and beyond January 9, 2024 / Jennifer Doudna / CRISPR / Danaher / Gene Editing CRISPR pioneer Jennifer Doudna, Ph.D., looks set...

January 12, 2024

1 2 3 … 11 12

Tag: FDA

Healthcare Industry News Weekly Wrap-Up: March 7, 2024

Metabolic News Weekly: March 5, 2024

Healthcare Industry News Weekly Wrap-Up: February 29, 2024

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

Healthcare Industry News Weekly Wrap-Up: February 16, 2024

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

Healthcare Industry News Weekly Wrap-Up: February 2, 2024

Healthcare Industry News Weekly Wrap-Up: January 26, 2024

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: FDA

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺